Safety parameters
| Safety parameter . | Chemotherapy only, n (%) . | Chemotherapy + lestaurtinib, n (%) . | P . |
|---|---|---|---|
| Death within 30 days of start of treatment | 7/109 (6) | 13/111 (12) | .24 |
| Grade 3 or 4 AE | 101/109 (93) | 104/111 (94) | .8 |
| Serious AE | 49/109 (45) | 61/111 (55) | .18 |
| Safety parameter . | Chemotherapy only, n (%) . | Chemotherapy + lestaurtinib, n (%) . | P . |
|---|---|---|---|
| Death within 30 days of start of treatment | 7/109 (6) | 13/111 (12) | .24 |
| Grade 3 or 4 AE | 101/109 (93) | 104/111 (94) | .8 |
| Serious AE | 49/109 (45) | 61/111 (55) | .18 |
P values were calculated using Fisher exact test.
AE indicates adverse event.